devinitorg/iati-policy-markers huggingface dataset:
Intensified implementation and monitoring of measles and rubella elimination strategies facilitated Intensified implementation and monitoring of measles and rubella elimination strategies facilitated Increased vaccination coverage for hard-to-reach populations and communities
Timely access to quality-assured influenza pandemic products is supported Timely access to quality-assured influenza pandemic products is supported Pandemic Influenza Preparedness Programme
Research and development agenda defined and research coordinated in line with public health priorities The Secretariat will support countries to:
increase the integration and coordination among centralized data repositories to share information on research and development pipelines, clinical trials data and health research system indicators globally;
enhance national and regional research and development capacity to develop priority, essential health products and utilize target product profiles in the development of new products to address public health needs; 
rapidly approve, introduce and roll out newly developed paediatric formulations, including support to strengthen post-marketing surveillance and pharmacovigilance specific to the paediatric; and
establish an mRNA research and developmentnetwork and convene scientific experts among participating countries to ensure intercountry and inter-region sharing ofscientific expertise and develop long-term capacity-building plan for health products research and development.

In producing technical products on norms/standard, data and research, the Secretariat will:
create effective cross-organizational mechanisms for research and development, including by establishing research and development networks;
develop a joint scientific advice procedure, whereby product developers may approach the Secretariat for advice on prequalification in order to enhance the accelerated development of products that meet the criteria for innovation and likely public health value;
update the global priority lists of antimicrobial-resistant bacteria pathogens of public importance; and
provide regular reviews and assessments of the development pipeline for treatments and vaccines in order to encourage continued investment in new strategies to promote the development of innovative antibacterial treatments and antifungal treatments and diagnostics. Improved access to essential medicines, vaccines, diagnostics and devices for primary health care
Effective logistics and operational support rapidly established and maintained Effective logistics and operational support rapidly established and maintained Populations affected by health emergencies have access to essential life-saving health services and public health interventions
Acute health emergencies rapidly responded to, leveraging relevant national and international capacities The Secretariat will support countries to:
convene and make recommendations on emergency grading based on risk assessments as established in the Emergency Response framework;
institutionalize response plans, mechanisms and processes, and implement emergency response activities through effective planning, budgeting, risk management and identification of financing gaps, ensuring continuous resource mobilization efforts and supporting resource allocation decisions through the Event Management Suite 2 (EMS2) structure;
redesign and adapt existing operations and supply chain and logistics platforms to manage large emergency events;
coordinate acute events, including the setup and coordination of incident management systems, and structures to ensure timely and efficient responses, and partner coordination through the Global Outbreak and Response Network (GOARN); and
strengthen linkages to regional and national emergency operation centres and national networks in order to ensure that such centres function as major strategic information hubs.

In producing technical products on norms/standard, data and research, the Secretariat will:
convene Emergency Committees under the International Health Regulations (2005), in the case of an extraordinary public health event, which will advise the Director-General on whether to declare a public health emergency of international concern;
develop rapid technical evidence-based guidance, standards and strategic response plans, collaborating with regional, national counterparts and all relevant stakeholders and partners to address evolving challenges; provide situational and epidemiological reports; monitor and evaluate response measures;
strengthen the global emergency operations platform, build stronger national and regional networks with a focus on improving standardization and interoperability, share and analyse critical real-time information for strategic decision-making and coordinating, mobilizing and rapidly deploying surge personnel through the Global Outbreak and Response Network (GOARN), emergency medical teams and other operational partnerships; and
ensure coherence between national logistics and distribution systems and global and regional platforms that provide access to critical countermeasures; ensure pre-negotiated and coordinated distribution contracts and the availability of appropriate stocks and supplier agreements; enable free movement of essential countermeasures, raw materials across borders. Acute health emergencies rapidly responded to, leveraging relevant national and international capacities
Norms and standards established and guidelines developed for environmental and occupational health risks and benefits associated with, for example, air and noise pollution, chemicals, waste, water and sanitation, radiation, and climate change and technical support provided at the regional and country levels for their implementation. Norms and standards established and guidelines developed for environmental and occupational health risks and benefits associated with, for example, air and noise pollution, chemicals, waste, water and sanitation, radiation, and climate change and technical support provided at the regional and country levels for their implementation. Reduced environmental threats to health
Improved quality and safety of medicines and other health technologies through norms, standards and guidelines, strengthening of regulatory systems, and prequalification Improved quality and safety of medicines and other health technologies through norms, standards and guidelines, strengthening of regulatory systems, and prequalification Improved access to and rational use of safe, efficacious and affordable quality medicines and other health technologies
Plans for effective &amp; efficient deployment of pandemic supplies are optimized Plans for effective &amp; efficient deployment of pandemic supplies are optimized Pandemic Influenza Preparedness Programme
Countries enabled to produce and analyse information on financial protection, equity and health expenditures and to use this information to track progress and inform decision-making The Secretariat will support countries to:
produce and analyse high-quality and policy-relevant data on the sources and uses of funds in the health sector in order to increase transparency and inform policy at country level, while also enhancing country capacity to provide robust data for the annual update of the WHO Global Health Expenditure Database;
carry out analyses of household survey data to enable policy-relevant analysis of financial barriers to access, coping mechanisms, forgone care and unmet need, and financial hardship arising from out-of-pocket payments for health services;
develop country-level health accounts, including disaggregation by funding source, input, function, disease and/or intervention (for example, HIV, tuberculosis, malaria, noncommunicable diseases, maternal and child services, immunization);
strengthen capacities for data collection, analysis and use for policy development and implementation; and
conduct in-depth policy analyses using routine administrative and survey data. Reduced number of people suffering financial hardship
Target product profiles for new vaccines and other immunization-related technologies, as well as research priorities, defined and agreed, in order to develop vaccines of public health importance and overcome barriers to immunization Target product profiles for new vaccines and other immunization-related technologies, as well as research priorities, defined and agreed, in order to develop vaccines of public health importance and overcome barriers to immunization Increased vaccination coverage for hard-to-reach populations and communities
?Leave no one behind? approach focused on equity, gender and human rights progressively incorporated and monitored ?Leave no one behind? approach focused on equity, gender and human rights progressively incorporated and monitored Strengthened leadership, governance and advocacy for health
Proven prevention strategies for priority/epidemic-prone diseases implemented at scale The Secretariat will step up leadership by:
advocating and providing support for accelerating the implementation of global disease-specific strategies, working with partners to scale these strategies to regional and national levels;
governing the International Coordination Group for Vaccine Provision to ensure equitable management of scarce resources at the global, regional and national levels;
coordinating the global emergency vaccine, medicine and reagent stockpiles, including strengthening forecast of vaccine stocks and pre-negotiated vaccine prices, working with networks and partners to ensure continuous equitable availability and access of critical countermeasures;
spearheading the development of a global strategy on viral haemorrhagic fevers; and
advocating for integrating yellow fever in catch-up multi-antigen vaccination campaigns including preventive campaigns in areas difficult to access.

The Secretariat will support countries to:
implement local prevention and control measures, ensuring access to life-saving interventions, such as vaccines, and to contextualize and implement global strategies, developing operational plans, including those for yellow fever, cholera and meningitis;
improve cooperation in, and coordination of, epidemic preparedness and response by strengthening regional and subregional networks with partners, including institutes of public health and national centres for disease control, professional associations and international partners; and
reinforce capabilities for the prevention, detection and control of cholera, viral haemorrhagic fevers, meningitis and yellow fever, including strengthening coordination to build stronger disease surveillance and laboratory systems capacities, and scaled-up capabilities to ensure that front-line health workers are protected and able to implement IPC best practices.

In producing technical products on norms/standard, data and research, the Secretariat will:
produce guidance on shortening the time taken to investigate an outbreak, confirm and respond for epidemic-prone diseases, among other guidance;
scale up the implementation of strategies for epidemic-prone diseases, including the adoption of new and enabling diagnostic technologies;
pilot the implementation of the guidance on managing risk of urban outbreaks of yellow fever in selected urban centres; and
implement the global roadmap to defeat meningitis by 2030, and together with expert networks, develop comprehensive global prevention and control policies and guidance; and
work with partners and countries to develop a global strategy to prevent and control viral haemorrhagic fevers. Proven prevention strategies for priority/epidemic-prone diseases implemented at scale
Proven prevention strategies for priority/epidemic-prone diseases implemented at scale The Secretariat will step up its leadership by:
advocating and providing support for the implementation of global disease strategies, including the equitable management of scarce resources at the global and regional level, through the International Coordinating Group on Vaccine Provision; 
managing the global emergency vaccine, medicine and reagent stockpiles, including through forecasting vaccine stocks and negotiating vaccine prices, will continue through WHO?s networks and partners to ensure availability and access;
spearheading the development of a global strategy on viral haemorrhagic fevers; and
advocating for the elimination of measles and rubella as part of the Immunization Agenda 2030.
The Secretariat will support countries to:
implement local prevention and control measures, ensuring access to life-saving interventions, such as vaccines, and to contextualize and implement global strategies, including those for yellow fever, cholera and meningitis;
improve cooperation in, and coordination of, epidemic preparedness and response by strengthening regional and subregional networks with partners, including institutes of public health and national centres for disease control, professional associations and international partners; and
develop country capabilities for the prevention, detection and control of cholera, viral haemorrhagic fevers, meningitis and yellow fever, including strengthening coordination to build surveillance and laboratory capacity, and scaled-up capabilities to ensure that front-line health workers are protected and able to implement infection prevention and control best practices. 
The Secretariat will:
produce normative products, including outbreak investigation guidance, to shorten the time to confirmation and response for all epidemic-prone diseases; 
scale up the implementation of strategies for epidemic-prone diseases, including the adoption of new and enabling technologies;
implement the global strategy for defeating meningitis by 2030, and together with expert networks, develop global prevention and control policies and guidance; and 
work with partners and countries to develop a global strategy to prevent and control viral haemorrhagic fevers. Proven prevention strategies for priority/epidemic-prone diseases implemented at scale
Polio legacy work plan finalized and under implementation globally Polio legacy work plan finalized and under implementation globally No cases of paralysis due to wild or type-2 vaccine-related poliovirus globally
Research priorities and comprehensive reviews of vaccination policies for new vaccines and other immunization-related technologies defined and agreed, in order to develop and introduce vaccines of public health importance and overcome barriers to immunization Research priorities and comprehensive reviews of vaccination policies for new vaccines and other immunization-related technologies defined and agreed, in order to develop and introduce vaccines of public health importance and overcome barriers to immunization Increased vaccination coverage for hard-to-reach populations and communities
Strategic priorities resourced in a predictable, adequate and flexible manner through strengthening partnerships The Secretariat will continue to develop its existing partnerships with Member States, donors, multilateral stakeholders, non-State actors and civil society organizations in order to advance more sustainable financing of the Organization and improve the quality of its funding; to secure predictable, adequate and flexible financing to deliver the GPW 13; and ultimately to accelerate collective progress towards the Sustainable Development Goals. New partnerships with entities that align policy and delivery will be sought and efforts will be made to continue to broaden the Organization?s funding base and increase the flexibility and predictability of its financing.
Together with its partners and contributors, the Secretariat will continue to streamline the management of funds and reduce transaction costs through fewer and longer agreements with lighter conditionalities to help WHO deliver on its priorities.
Supported by enhanced donor intelligence and income-forecasting capacity, the Secretariat will continue to strengthen and deepen its relationships with its donors and is committed to strong dialogue to ensure shared priority-setting and mutually reinforcing commitments. Clear priorities, backed up by adequate and dependable resourcing, will help the Secretariat to plan and deliver in an effective and efficient way.
The Secretariat will make use of its new Contributor Engagement Management system to facilitate the streamlining of resource mobilization activities and ensure improved coordination of the negotiation of agreements, and subsequent associated reporting.
With the objective to promote the understanding of health on the political agenda, strategic plans will be developed and implemented for further engagement with multilateral organizations, parliaments, civil society and the private sector. Strengthened leadership, governance and advocacy for health
Mitigate the risk of the emergence and re-emergence of high-threat pathogens and improve pandemic preparedness The Secretariat will step up its leadership by:
establishing, leading, managing and strengthening the technical networks and global partnerships for research, development of countermeasures, prevention, control and mitigation of novel, high-threat infectious hazards;
transitioning poliovirus containment functions to ensure the sustainability of support for the safe and secure retention of polioviruses in laboratories and vaccine production facilities for research, diagnostics and vaccine production; 
developing global strategies, with regional specificities, guidance and tools to prevent and manage emerging or re-emerging high-threat pathogens; and
strengthening the implementation of the Pandemic Influenza Preparedness Framework, and coordinating the Global Influenza Surveillance and Response System.
The Secretariat will support countries to:
prepare, prevent and manage outbreaks of emerging or re-emerging high-threat pathogens, and scale up interventions based on context and transmission patterns. This support will include the revision of pandemic preparedness plans taking into account specific and unknown (disease X) pathogens;
develop and implement robust infection prevention and control strategies at the national level to ensure that core components, including personal protective equipment, are adequate and available; 
better understand community beliefs and behaviours in order to successfully implement community engagement activities in mitigating and managing outbreaks of high-risk pathogens; 
implement the global influenza strategy 2019?2030 in order to strengthen detection of emerging influenza viruses, scale up national sustainable influenza programmes and develop new tools for disease prevention and control; and
strengthen national capacity to guarantee the safe and secure retention of polioviruses, in line with the global action plan for poliovirus containment (GAPIII), and ensure that facilities that retain polioviruses are fully certified, as outlined in the WHO Containment Certification Scheme.
The Secretariat will:
produce standard protocols, guidance and control strategies to prevent, manage, and reduce the health and security impacts of emerging and re-emerging pathogens and biosecurity hazards, including respiratory pathogens and vector-borne diseases;
produce pandemic preparedness plans for unknown diseases (disease X), and guidelines and strategies for accelerating research on emerging pathogens;
produce collaboratively evidence-based pandemic influenza preparedness packages, including guidance, standard operating procedures, training materials and platforms and continue to provide global influenza vaccine strain recommendations to inform the composition of the seasonal (or pandemic) influenza vaccine; and
operationalize the WHO Advisory Committee on Variola Virus Research, and oversee the biosecurity inspections of the two global repositories of variola virus where the last remaining stocks of live variola virus have been held since the eradication of smallpox. Epidemics and pandemics prevented
Effective and efficient human resources management and coordination in place Effective and efficient human resources management and coordination in place Effective and efficient management administration consistently established across the Organization
Public health objectives addressed in implementation of multilateral agreements and conventions and initiatives on the environment, the Paris Agreement (as adopted by United Nations Framework Convention on Climate Change), international labour conventions related to occupational health and safety, and in relation to the Sustainable Development Goals Public health objectives addressed in implementation of multilateral agreements and conventions and initiatives on the environment, the Paris Agreement (as adopted by United Nations Framework Convention on Climate Change), international labour conventions related to occupational health and safety, and in relation to the Sustainable Development Goals Reduced environmental threats to health
Capacities for emergency preparedness strengthened in all countries Critical country core capacities in all countries; country emergency preparedness capacity; IHR (International Health Regulations) implementation; disaster risk management and resilience; environmental risks; health workforce strategies; environmental and occupational risk. Countries prepared for health emergencies
Global expert networks and innovative mechanisms developed to manage new and evolving high-threat infectious hazards (such as for clinical management, laboratories, social science, and data modelling) Global expert networks and innovative mechanisms developed to manage new and evolving high-threat infectious hazards (such as for clinical management, laboratories, social science, and data modelling) All countries are equipped to mitigate risks from high-threat infectious hazards
Countries enabled to implement evidence-based malaria strategic plans, with focus on effective coverage of vector control interventions and diagnostic testing and treatment, therapeutic efficacy and insecticide resistance monitoring and surveillance, through strengthening of capacity for enhanced malaria reduction Countries enabled to implement evidence-based malaria strategic plans, with focus on effective coverage of vector control interventions and diagnostic testing and treatment, therapeutic efficacy and insecticide resistance monitoring and surveillance, through strengthening of capacity for enhanced malaria reduction Increased access of populations at risk to preventive interventions, diagnostic confirmation of malaria and first-line antimalarial treatment
Country Programme Burkina Faso A la demande du Gouvernement du Burkina Faso et suite à une série de consultations entre le Gouvernement et l#ONUDI, les plus récentes en marge de la Conférence générale de l#ONUDI en novembre 2011et lors de la mission de formulation en novembre 2012, il a été décidé de concevoir un nouveau cadre de coopération technique sous la forme d#un Programme Pays(PP). Celui-ci constitue un ensemble d#interventions spécialisées. L#approche vise à : (i) cibler les différentes interventions d#appui au secteur productif sur des chaines de valeurs à fort potentiel de croissance; (ii) assurer la cohérence entre l#appui de l#ONUDI, les agences du système des Nations Unies et les bailleurs de fonds bi et multilatéraux. Le programme sera axé autour de projets de coopération technique autonomes et flexible. Une approche de projets plus autonomes a été adoptée dans l#optique de faciliter la mobilisation de fonds et de contribuer à une mise en #uvre plus efficiente. Cependant, des synergies potentielles entre les différents projets seront recherchées en fonction de la disponibilité des ressources et/ou du calendrier de mise en #uvre.
National inventory of banks of used or unwanted controlled substances and a plan The objectives are to conduct an inventory of unused/unwanted ODS refrigerants and formulate a national action plan for sound management of refrigerants, including identifying key stakeholders, assessing unused ODS, providing training on good practices and determining priorities, as well as lay the foundation for a comprehensive refrigerant management plan by getting commitment from various st akeholders.